SEC Filing Summary: Synaptogenix, Inc. (SNPX)
Business Context and Reporting Period
This Form 8-K Current Report was filed on April 4, 2024, by Synaptogenix, Inc., a Delaware corporation and emerging growth company. The report details the implementation of a corporate action previously approved by stockholders at the annual meeting held on December 20, 2023.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a capital structure adjustment rather than operational financial performance.
Material Changes
- Reverse Stock Split: The Company effected a one-time reverse stock split of its common stock at a ratio of 1-for-25.
- Effective Time: The split became effective at 5:00 p.m. Eastern Time on April 4, 2024, following the close of trading on The Nasdaq Capital Market.
- Share Conversion: Every 25 shares of issued and outstanding common stock were automatically converted into one share of common stock.
- Par Value: There was no change in the par value per share ($0.0001).
- Adjustments: Proportionate adjustments were made to the exercise price and share counts for all outstanding stock options, warrants, and convertible securities.
- Fractional Shares: Stockholders entitled to fractional shares received cash payments based on the closing sales price of the stock on April 4, 2024, adjusted for the split.
- Trading Details: The stock continues to trade under the symbol "SNPX" with a new CUSIP number: 87167T300.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure that the summary is qualified by the full text of the Certificate of Amendment. The primary purpose of the filing is to disclose the completion of the reverse stock split.
Investor Verification Checklist
- Verify the new CUSIP number (87167T300) for accurate trading and record-keeping.
- Confirm the adjusted number of shares held in brokerage accounts post-split.
- Review the adjusted exercise prices and share quantities for any held stock options or warrants.
- Check for cash payments received in lieu of fractional shares.
- Review the full text of the Certificate of Amendment (Exhibit 3.1) for complete legal terms.